Enovis Corp

NYSE:ENOVHealthcareCBOEFTSE:MRUTrussell2000

$21.33−1.20%LiveIn session · ≈ AED 78.33 · Market cap $1.23B · Next earnings Thu 5 Nov

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.1	0.7	0.0	0.0	0.0	0.0	−24.5%
Cash & short-term investments	0.1	0.7	0.0	0.0	0.0	0.0	−24.5%
Receivables	0.5	0.3	0.3	0.3	0.4	0.4	+8.8%
Inventory	0.6	0.4	0.4	0.5	0.5	0.6	+6.8%
Total current assets	1.4	2.3	0.8	0.9	1.1	1.2	+5.3%
Property, plant & equipment	0.7	0.3	0.3	0.3	0.5	0.6	+22.4%
Goodwill & intangibles	5.0	3.1	3.1	3.2	3.0	2.0	−35.1%
Long-term investments	0.0	0.0	0.0	0.0	0.0	0.0	+4.9%
Total assets	7.4	8.5	4.3	4.5	4.7	3.8	−18.7%
Payables	0.3	0.2	0.1	0.1	0.2	0.2	+4.7%
Short-term debt	0.1	0.0	0.2	0.0	0.0	0.1	+198.3%
Total current liabilities	0.8	1.0	0.6	0.4	0.5	0.6	+13.1%
Long-term debt	2.2	2.1	0.0	0.5	1.3	1.3	−3.6%
Total debt	2.4	2.2	0.3	0.5	1.4	1.4	−1.8%
Net debt	2.3	1.5	0.3	0.5	1.4	1.3	−1.0%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	+4.3%
Total liabilities	3.8	3.9	0.8	1.1	2.2	2.3	+8.7%
Total equity	3.5	4.6	3.4	3.4	2.6	1.5	−41.9%
Retained earnings	0.5	0.6	0.6	0.5	(0.3)	(1.5)	−418.5%

USD billionsUpdated Thu 6 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.